D.E. Shaw & Co
LVACU

D.E. Shaw & Co’s LAVA Medtech Acquisition Corp. Unit LVACU Stock Holding History

D.E. Shaw & Co’s Portfolio LVACU Stock Details LVACU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-200,000
Closed -$2.1M – 6269
2021
Q4 		$2.1M Buy
+200,000
New +$2.02M ﹤0.01% 3307

Other funds holding LVACU

CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
MP
Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return
BCM
Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
CIM
Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
CM
Cohanzick Management Pleasantville, New York $231K AUM 3.17% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

D.E. Shaw & Co's LVACU Position: Q1 2022 in Review

D.E. Shaw & Co sold out of LAVA Medtech Acquisition Corp. Unit (LVACU) in Q1 2022, closing a stake of 200,000 shares — an estimated $2.1M sold.

D.E. Shaw & Co first reported a position in LVACU in Q4 2021 and held it in 1 quarter. The position peaked at $2.1M in Q4 2021. 17 funds tracked by Wall St. Rank hold LVACU as of Q1 2022.

  • D.E. Shaw & Co reported no remaining LAVA Medtech Acquisition Corp. Unit position as of Q1 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 200,000 LAVA Medtech Acquisition Corp. Unit shares in Q1 2022, an estimated $2.1M.
  • D.E. Shaw & Co first reported a position in LAVA Medtech Acquisition Corp. Unit in Q4 2021 and held it in 1 quarter.
  • D.E. Shaw & Co's LAVA Medtech Acquisition Corp. Unit position peaked at $2.1M in Q4 2021.
  • 17 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Unit as of Q1 2022.

Based on D.E. Shaw & Co's 13F filing for Q1 2022, filed 16 May 2022.